1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Products and Services 5.2.5 Competitive Rivalry within the Industry 6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 6.1 Drivers 6.1.1 Increasing use of Telecardiology 6.1.2 Ease-of-use and Portability of Cardiac Arrhythmia Monitoring Devices 6.1.3 Development of Smart Cardiac Monitors 6.2 Restraints 6.2.1 Quality Cannot be Controlled by the Devices 6.2.2 High Cost of Remote Cardiac Arrhythmia Monitoring 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Devices 7.1.1 Cardiac Telemetry Devices 7.1.2 Event Monitoring Devices 7.1.3 Continuous Rhythm Monitoring Devices 7.1.4 Holter Monitoring Devices 7.2 By Service Providers 7.2.1 Mobile Cardiac Telemetry Monitoring Service Providers 7.2.2 Independent Diagnostic Testing Facilities/Clinics 7.3 By Geography 7.3.1 North America 7.3.1.1 US 7.3.1.2 Canada 7.3.1.3 Mexico 8. Competitive Landscape 8.1 Mergers & Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Products Launches 9. Key Players 9.1 Applied Cardiac Systems 9.2 Aurora Resurgence (Cardiac Science Corp) 9.3 Biotelemetry 9.4 GE Healthcare 9.5 iRhythm 9.6 Medi-Lynx 9.7 Medtronics 9.8 Philips Healthcare *List not Exhaustive 10. Future of the Market 11. Disclaimer 1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Products and Services 5.2.5 Competitive Rivalry within the Industry 6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 6.1 Drivers 6.1.1 Increasing use of Telecardiology 6.1.2 Ease-of-use and Portability of Cardiac Arrhythmia Monitoring Devices 6.1.3 Development of Smart Cardiac Monitors 6.2 Restraints 6.2.1 Quality Cannot be Controlled by the Devices 6.2.2 High Cost of Remote Cardiac Arrhythmia Monitoring 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Devices 7.1.1 Cardiac Telemetry Devices 7.1.2 Event Monitoring Devices 7.1.3 Continuous Rhythm Monitoring Devices 7.1.4 Holter Monitoring Devices 7.2 By Service Providers 7.2.1 Mobile Cardiac Telemetry Monitoring Service Providers 7.2.2 Independent Diagnostic Testing Facilities/Clinics 7.3 By Geography 7.3.1 North America 7.3.1.1 US 7.3.1.2 Canada 7.3.1.3 Mexico 8. Competitive Landscape 8.1 Mergers & Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Products Launches 9. Key Players 9.1 Applied Cardiac Systems 9.2 Aurora Resurgence (Cardiac Science Corp) 9.3 Biotelemetry 9.4 GE Healthcare 9.5 iRhythm 9.6 Medi-Lynx 9.7 Medtronics 9.8 Philips Healthcare *List not Exhaustive 10. Future of the Market 11. Disclaimer

GE Healthcare, Medtronics, Aurora Resurgence (Cardiac Science Corp), Medi-Lynx, Philips Healthcare, Applied Cardiac Systems, iRhythm, Biotelemetry